Global X Genomics & Biotechnology ETF (NASDAQ: GNOM) stock price, news, charts, stock research, profile.
Open | - |
High | - |
52 Wk High | 12.58 |
AUM | 87.26M |
Dividend | - |
Ex-Div Date | - |
Volume | - |
Market Cap | $14.08B |
Mgmt Fee | 0.5% |
P/E Ratio | 38.23 |
Prev. Close | $11.60 |
Low | - |
52 Wk Low | 8.63 |
Shares Out | 9.12M |
Yield | - |
Div. Freq | - |
Avg. Volume Daily | 60.67K |
Beta | 1.11 |
Avg. Expense Ratio | 0.5% |
P/B Ratio | 3.38 |
You can purchase shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) through any online brokerage.
There are no as such competitors for Global X Genomics & Biotechnology ETF.
There is no analysis for Global X Genomics & Biotechnology ETF.
There is no analysis for Global X Genomics & Biotechnology ETF to provide a consensus price target.
The stock price for Global X Genomics & Biotechnology ETF (NASDAQ: GNOM) is $11.6 last updated July 17, 2024 at 4:15 PM EDT.
There are no upcoming dividends for Global X Genomics & Biotechnology ETF.
Global X Genomics & Biotechnology ETF does not have any upcoming earnings scheduled.
There is no upcoming split for Global X Genomics & Biotechnology ETF.
Sector | Healthcare |
Category | Mid Performer-Mid Growth |
Investment Style | Mid Cap Growth |
Fund Inception | Apr 5, 2019 |
Managers | Vanessa Yang Sandy Lu Wayne Xie Nam To |
Definition | Most of the stocks in this Equity Fund have average financial performance and average growth potential |
Symbol | Name | Share % |
---|---|---|
ALNY | Alnylam Pharmaceutical... | 6.45% |
RNA | Avidity Biosciences In... | 5.49% |
SRPT | Sarepta Therapeutics I... | 4.85% |
NTRA | Natera Inc | 4.52% |
TECH | Bio-Techne Corp | 4.31% |
ARWR | Arrowhead Pharmaceutic... | 4.26% |
MRNA | Moderna Inc | 4.16% |
NTLA | Intellia Therapeutics ... | 3.97% |
MYGN | Myriad Genetics Inc | 3.97% |
SG | Qiagen N.V. | 3.78% |